Skip to main content

TEVA 7769 Pill - white oval

Pill with imprint TEVA 7769 is White, Oval and has been identified as Everolimus 10 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Everolimus is used in the treatment of Neuroendocrine Carcinoma; Breast Cancer; Organ Transplant, Rejection Prophylaxis; Pancreatic Cancer; Renal Angiomyolipoma and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7769

Everolimus 10 mg TEVA 7769

Everolimus

Imprint
TEVA 7769
Strength
10 mg
Color
White
Shape
Oval
Availability
Prescription only
Drug Class
MTOR inhibitors, Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-7769

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.